MIAT and metabolic syndrome: To assess the chromosomal origins and the relative impact of MIAT’s contributions to inflammation, we segregated the predicted MIAT miR targets according to their chromosomal origins and reported clinical associations (Figure 2), and identified a complex profile of MIAT’s contribution to MetS and sepsis.